Twist Bioscience (TWST) EBT Margin (2017 - 2026)
Twist Bioscience (TWST) posted quarterly EBT Margin of 39.72% for Q1 2026, up 247.0% year-over-year from 11.45% in Q1 2025, and down 36.15% quarter-over-quarter from 29.18% in Q4 2025.
Twist Bioscience (TWST) EBT Margin (2017 - 2026) Analysis & Trends
Twist Bioscience (TWST) has reported EBT Margin for 10 consecutive years, with 39.72% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBT Margin rose 247.0% year-over-year to 39.72%; the TTM figure through Mar 2026 stood at 19.67% (up 3521.0% YoY), while the FY2025 annual figure was 20.43%, up 4608.0% from the prior year.
- EBT Margin declined to 39.72% in Q1 2026 per TWST's latest filing, from 29.18% in the prior quarter.
- Across five years, EBT Margin topped out at 21.43% in Q2 2025 and bottomed at 126.37% in Q1 2022.
- Historically, EBT Margin has averaged 63.17% across 5 years, with a median of 59.98% in 2023.
- Annual changes were most pronounced in 2024 — EBT Margin tumbled 1574 bps — and 2025, when it jumped 12623 bps.
- Twist Bioscience's EBT Margin stood at 76.96% in 2022, then climbed by 22 bps to 59.98% in 2023, then jumped by 41 bps to 35.5% in 2024, then gained by 18 bps to 29.18% in 2025, then tumbled by 36 bps to 39.72% in 2026.
- Business Quant data shows TWST's EBT Margin at 39.72% in Q1 2026, 29.18% in Q4 2025, and 27.15% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 17.21% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 6.89% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 34.29% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 28.17% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 10.36% |
| 10 | Twist Bioscience | 9.55 Bn | 9.38 Bn | 62.45 Mn | -29.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.35% |
| Mar 31, 2026 | -39.72% |
| Dec 31, 2025 | -29.18% |
| Sep 30, 2025 | -27.15% |
| Jun 30, 2025 | 21.43% |
| Mar 31, 2025 | -42.19% |
| Dec 31, 2024 | -35.50% |
| Sep 30, 2024 | -41.02% |
| Jun 30, 2024 | -104.81% |
| Mar 31, 2024 | -59.95% |
| Dec 31, 2023 | -59.98% |
| Sep 30, 2023 | -69.41% |
| Jun 30, 2023 | -89.07% |
| Mar 31, 2023 | -97.18% |
| Dec 31, 2022 | -76.96% |
| Sep 30, 2022 | -88.69% |
| Jun 30, 2022 | -108.11% |
| Mar 31, 2022 | -126.37% |
| Dec 31, 2021 | -133.20% |
| Sep 30, 2021 | -107.77% |